Every drug that reaches patients has a safety story that doesn’t end at approval — and Pharmacovigilance is the science that monitors that story. It is the system through which adverse drug reactions are detected, reported, assessed, and prevented after a medicine enters the market. In India, Pharmacovigilance is regulated through the Pharmacovigilance Programme of India (PvPI) run under CDSCO, and internationally through the WHO-UMC Uppsala Monitoring Centre. For B Pharma students, this subject is directly relevant to careers in drug safety, clinical research, regulatory affairs, and hospital pharmacy.
These Pharmacovigilance notes are prepared as per the PCI-approved B Pharma 8th semester syllabus 2025–26, structured unit-wise with clear topic descriptions before each PDF download. The notes cover everything from ADR classification and signal detection to ICH guidelines, MedDRA coding, PSUR preparation, and CDSCO regulatory requirements — giving you both exam readiness and real professional context.
Download Pharmacovigilance Notes PDF – Unit Wise
Click below to download free PDFs for each unit:
Course Units
Unit 1: Fundamentals of Pharmacovigilance & Adverse Drug Reactions
Topics Covered: The history, importance, and regulatory framework of pharmacovigilance, WHO and PvPI programs, and comprehensive concepts of adverse drug reactions including detection, assessment, management, and terminology.
Unit 2: Drug Classification, Coding Systems & Pharmacovigilance Programs
Topics Covered: Focuses on drug and disease classification systems, pharmacovigilance coding dictionaries like MedDRA and WHO-DD, information resources, and establishment of pharmacovigilance programs in hospitals, industry, CROs, and at national level.
Unit 3: Vaccine Safety, Surveillance Methods & Risk Communication
Topics Covered: Includes vaccine pharmacovigilance, adverse events following immunization, passive and active surveillance methods, observational studies, and effective communication strategies in drug safety and crisis management.
Unit 4: Safety Data Management & ICH Pharmacovigilance Guidelines
Topics Covered: Safety data generation across preclinical, clinical, and post-marketing phases along with ICH guidelines, case safety reporting, PSURs, pharmacovigilance planning, and GCP compliance.
Unit 5: Advanced Drug Safety, Pharmacogenomics & Regulatory Requirements
Topics Covered: Focuses on pharmacogenomics of ADRs, drug safety evaluation in special populations, CIOMS structure and forms, and Indian CDSCO regulations with comparison to global pharmacovigilance requirements.
What is Pharmacovigilance?
Pharmacovigilance is the science and practice of monitoring, detecting, assessing, and preventing adverse effects of medicines. It plays a crucial role in ensuring that drugs available in the market remain safe and effective for patients even after they are approved.
Unlike subjects focused on drug development, pharmacovigilance is concerned with what happens after a drug reaches real patients—how it behaves in diverse populations, what side effects may arise, and how risks can be minimized.
These notes will help you understand important areas such as:
- Introduction to Pharmacovigilance & Drug Safety
Basic concepts, objectives, and the importance of monitoring adverse drug reactions (ADRs). - Adverse Drug Reactions (ADR) and Classification
Types of ADRs, their causes, severity levels, and how they impact patient safety. - Drug Safety Monitoring Systems
National and international pharmacovigilance programs, reporting systems, and databases used to track drug safety. - Causality Assessment of ADRs
Methods used to determine whether a drug is responsible for a particular adverse event. - Signal Detection and Risk Management
Identifying new safety signals from data and implementing strategies to reduce risks. - Pharmacovigilance in Clinical Trials
Safety monitoring during different phases of clinical research and reporting requirements. - Regulatory Guidelines and Reporting
Role of regulatory authorities and guidelines for reporting ADRs and ensuring compliance. - Pharmacovigilance in Special Populations
Drug safety considerations in children, elderly patients, pregnant women, and patients with chronic diseases.
Frequently Asked Questions (FAQ)
Q1. Is Pharmacovigilance a viable career path for B Pharma graduates in India?
Absolutely. Pharmacovigilance is one of the fastest-growing sectors in the Indian pharmaceutical industry, especially in IT-hub cities like Pune, Bangalore, and Hyderabad. Graduates typically start as Drug Safety Associates or PV Scientists, responsible for processing ICSRs (Individual Case Safety Reports). Mastering the concepts in these notes—specifically MedDRA coding and causality assessment—is essential for clearing technical interviews in MNCs and CROs.
Q2. How do the PvPI (India) and WHO-UMC programs work together?
It is a common exam question and a point of confusion. The Pharmacovigilance Programme of India (PvPI), governed by the CDSCO, acts as the national reporting body. All safety data collected within India is filtered through PvPI and then sent to the WHO-Uppsala Monitoring Centre (UMC) in Sweden. This global collaboration ensures that a signal detected in India can contribute to a worldwide safety alert if necessary.
Q3. Why are MedDRA and WHO-DD coding dictionaries so critical in these units?
In Unit 2, you will encounter these coding systems. They are necessary because medical terms for side effects vary across different languages and regions. MedDRA (Medical Dictionary for Regulatory Activities) and WHO-DD (Drug Dictionary) provide a “universal language.” This standardization allows a safety report generated in India to be perfectly understood by a regulatory officer in the US or Europe without any clinical misinterpretation.
Q4. What are the high-weightage topics for the 8th Semester final theory exam?
Based on university patterns, students should focus heavily on Unit 1 (ADR Classification) and Unit 4 (ICH Guidelines). Topics like the “Naranjo Scale” for causality assessment and “PSUR” (Periodic Safety Update Reports) preparation are almost always included in long-answer questions. To see how these topics are framed by examiners, we recommend reviewing the B Pharma Previous Year Question Papers alongside these unit-wise PDFs.